| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Apr 01, 2024 | Option Exercise | $3.08 | 157 | 484 | 133,741 | Apr 03, 2024, 05:06 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Jan 02, 2024 | Option Exercise | $2.28 | 157 | 358 | 133,898 | Jan 03, 2024, 05:21 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Oct 02, 2023 | Option Exercise | $3.83 | 1,184 | 4,535 | 9,055 | Oct 04, 2023, 04:23 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Mar 31, 2023 | Option Exercise | $3.08 | 480 | 1,478 | 10,390 | Apr 04, 2023, 05:05 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Dec 31, 2022 | Option Exercise | $0.15 | 1,720 | 258 | 220,252 | Jan 04, 2023, 05:09 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Sep 30, 2022 | Option Exercise | $0.22 | 1,719 | 383 | 221,972 | Oct 04, 2022, 05:05 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Jun 30, 2022 | Option Exercise | $0.39 | 1,719 | 669 | 223,691 | Jul 05, 2022, 05:01 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Mar 31, 2022 | Option Exercise | $0.65 | 3,469 | 2,255 | 225,410 | Apr 04, 2022, 05:09 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Dec 31, 2021 | Option Exercise | $1.02 | 1,250 | 1,275 | 153,879 | Jan 04, 2022, 04:40 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Sep 30, 2021 | Option Exercise | $1.39 | 1,480 | 2,057 | 155,129 | Oct 01, 2021, 05:12 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Jun 30, 2021 | Option Exercise | $3.51 | 3,083 | 10,821 | 95,750 | Jul 02, 2021, 04:36 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Mar 31, 2021 | Option Exercise | $6.84 | 1,945 | 13,304 | 98,833 | Apr 02, 2021, 12:14 PM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Dec 31, 2020 | Option Exercise | $1.58 | 2,378 | 3,757 | 286,262 | Jan 05, 2021, 12:00 AM | |
| VYNE | VYNE Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Sep 30, 2020 | Option Exercise | $1.66 | 2,378 | 3,947 | 288,640 | Oct 02, 2020, 04:32 PM | |
| MNLO | Menlo Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Jun 30, 2020 | Option Exercise | $1.73 | 2,378 | 4,114 | 291,018 | Jul 02, 2020, 04:25 PM | |
| MNLO | Menlo Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Apr 06, 2020 | Option Exercise | $1.40 | 3,763 | 5,268 | 180,901 | Apr 07, 2020, 05:22 PM | |
| MNLO | Menlo Therapeutics Inc. | Stuart Iain | Chief Scientific Officer | Mar 31, 2020 | Option Exercise | $2.68 | 1,940 | 5,199 | 59,452 | Apr 02, 2020, 04:41 PM | |
| FOMX | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Dec 31, 2019 | Option Exercise | $3.28 | 514 | 1,686 | 62,337 | Jan 03, 2020, 05:23 PM | |
| FOMX | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Sep 30, 2019 | Option Exercise | $3.07 | 673 | 2,066 | 62,851 | Oct 02, 2019, 04:20 PM | |
| FOMX | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Jul 01, 2019 | Sale | $2.35 | 951 | 2,235 | 63,524 | Jul 03, 2019, 04:26 PM | |
| FOMX | Foamix Pharmaceuticals Ltd. | Stuart Iain | Chief Scientific Officer | Apr 01, 2019 | Sale | $3.75 | 1,696 | 6,360 | 64,475 | Apr 03, 2019, 12:00 AM | |
| FOMX | Foamix Pharmaceuticals Ltd. | Stuart Iain | SVP R&D | Nov 08, 2018 | Sale | $4.58 | 683 | 3,128 | 33,602 | Nov 13, 2018, 06:16 AM | |
| FOMX | Foamix Pharmaceuticals Ltd. | Stuart Iain | SVP R&D | Aug 08, 2018 | Sale | $5.68 | 2,715 | 15,421 | 34,285 | Aug 09, 2018, 04:05 PM |
Menu